Teva Pharmaceutical reported $2.8B in Cash and Equivalent for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aspen Pharmacare APN:SJ ZAR 6.18B 1.69B
Kalbe Farma Tbk Pt KLBF:IJ IDR 1.59T 475.04B
Richter Gedeon RICHT:HB HUF 71.79B 12.03B
Sh Fosun Pharma 600196:CH CNY 14.87B 3.43B
Teva Pharmaceutical TEVA:IT USD 2.8B 576M